50242-210 : Gavreto 100 mg Oral Capsule


NDC: 50242-210
Labeler: Genentech, Inc.
Product Type: Human Prescription Drug
Drug Name:  Gavreto
Dosage Form: Oral Capsule
Application #: NDA213721
Rev. Date: 


NDC Package Codes:

  • 50242-210-12: 1 BOTTLE IN 1 CARTON (50242‑210‑12) > 120 CAPSULE IN 1 BOTTLE
  • 50242-210-60: 1 BOTTLE IN 1 CARTON (50242‑210‑60) > 60 CAPSULE IN 1 BOTTLE
  • 50242-210-83: 1 BOTTLE IN 1 CARTON (50242‑210‑83) > 60 CAPSULE IN 1 BOTTLE
  • 50242-210-86: 1 BOTTLE IN 1 CARTON (50242‑210‑86) > 120 CAPSULE IN 1 BOTTLE
  • 50242-210-90: 1 BOTTLE IN 1 CARTON (50242‑210‑90) > 90 CAPSULE IN 1 BOTTLE

Active Ingredients:

  • Pralsetinib

Dosage Strength:

  • 100 mg

Pharmaceutical Classes:

  • Kinase Inhibitor [EPC]
  • Rearranged during Transfection (RET) Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 72064-210 Pralsetinib by Blueprint Medicines Corporation

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 50242-210 QR Code

< Prev: 50242-176Next: 50242-214 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.